
### [MONDO:0000351](http://purl.obolibrary.org/obo/MONDO_0000351)
**Label:** hypermethioninemia (disease)

**Subclasses:** [MONDO:0011698](http://purl.obolibrary.org/obo/MONDO_0011698) (glycine N-methyltransferase deficiency), [MONDO:0013676](http://purl.obolibrary.org/obo/MONDO_0013676) (hypermethioninemia due to adenosine kinase deficiency), [MONDO:0013404](http://purl.obolibrary.org/obo/MONDO_0013404) (hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase), 

**Mapped go classes:** [GO:0006641](http://purl.obolibrary.org/obo/GO_0006641) (triglyceride metabolic process), [GO:0006166](http://purl.obolibrary.org/obo/GO_0006166) (purine ribonucleoside salvage), [GO:0043621](http://purl.obolibrary.org/obo/GO_0043621) (protein self-association), [GO:0006169](http://purl.obolibrary.org/obo/GO_0006169) (adenosine salvage), [GO:0051289](http://purl.obolibrary.org/obo/GO_0051289) (protein homotetramerization), [GO:0003723](http://purl.obolibrary.org/obo/GO_0003723) (RNA binding), [GO:0005507](http://purl.obolibrary.org/obo/GO_0005507) (copper ion binding), [GO:0051287](http://purl.obolibrary.org/obo/GO_0051287) (NAD binding), [GO:0002439](http://purl.obolibrary.org/obo/GO_0002439) (chronic inflammatory response to antigenic stimulus), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0010613](http://purl.obolibrary.org/obo/GO_0010613) (positive regulation of cardiac muscle hypertrophy), [GO:0016773](http://purl.obolibrary.org/obo/GO_0016773) (phosphotransferase activity, alcohol group as acceptor), [GO:0044209](http://purl.obolibrary.org/obo/GO_0044209) (AMP salvage), [GO:0042745](http://purl.obolibrary.org/obo/GO_0042745) (circadian sleep/wake cycle), [GO:0006175](http://purl.obolibrary.org/obo/GO_0006175) (dATP biosynthetic process), [GO:0007584](http://purl.obolibrary.org/obo/GO_0007584) (response to nutrient), [GO:0046500](http://purl.obolibrary.org/obo/GO_0046500) (S-adenosylmethionine metabolic process), [GO:0042102](http://purl.obolibrary.org/obo/GO_0042102) (positive regulation of T cell proliferation), [GO:0006656](http://purl.obolibrary.org/obo/GO_0006656) (phosphatidylcholine biosynthetic process), [GO:0006730](http://purl.obolibrary.org/obo/GO_0006730) (one-carbon metabolic process), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0017174](http://purl.obolibrary.org/obo/GO_0017174) (glycine N-methyltransferase activity), [GO:0019510](http://purl.obolibrary.org/obo/GO_0019510) (S-adenosylhomocysteine catabolic process), [GO:0008168](http://purl.obolibrary.org/obo/GO_0008168) (methyltransferase activity), [GO:0004001](http://purl.obolibrary.org/obo/GO_0004001) (adenosine kinase activity), [GO:0006144](http://purl.obolibrary.org/obo/GO_0006144) (purine nucleobase metabolic process), [GO:0043005](http://purl.obolibrary.org/obo/GO_0043005) (neuron projection), [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0046085](http://purl.obolibrary.org/obo/GO_0046085) (adenosine metabolic process), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:0044342](http://purl.obolibrary.org/obo/GO_0044342) (type B pancreatic cell proliferation), [GO:0016594](http://purl.obolibrary.org/obo/GO_0016594) (glycine binding), [GO:0016310](http://purl.obolibrary.org/obo/GO_0016310) (phosphorylation), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:0033353](http://purl.obolibrary.org/obo/GO_0033353) (S-adenosylmethionine cycle), [GO:0006111](http://purl.obolibrary.org/obo/GO_0006111) (regulation of gluconeogenesis), [GO:0005542](http://purl.obolibrary.org/obo/GO_0005542) (folic acid binding), [GO:0004013](http://purl.obolibrary.org/obo/GO_0004013) (adenosylhomocysteinase activity), [GO:0006555](http://purl.obolibrary.org/obo/GO_0006555) (methionine metabolic process), [GO:0005977](http://purl.obolibrary.org/obo/GO_0005977) (glycogen metabolic process), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0071268](http://purl.obolibrary.org/obo/GO_0071268) (homocysteine biosynthetic process), [GO:0016740](http://purl.obolibrary.org/obo/GO_0016740) (transferase activity), [GO:0030554](http://purl.obolibrary.org/obo/GO_0030554) (adenyl nucleotide binding), [GO:0016301](http://purl.obolibrary.org/obo/GO_0016301) (kinase activity), [GO:0032259](http://purl.obolibrary.org/obo/GO_0032259) (methylation), [GO:0016787](http://purl.obolibrary.org/obo/GO_0016787) (hydrolase activity), 

**Class expressions from DL-Learner:**

- [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome) 53.12%
- [GO:0017174](http://purl.obolibrary.org/obo/GO_0017174) (glycine N-methyltransferase activity) 53.12%
- [GO:0016802](http://purl.obolibrary.org/obo/GO_0016802) (trialkylsulfonium hydrolase activity) 53.12%
- [GO:0016594](http://purl.obolibrary.org/obo/GO_0016594) (glycine binding) 53.12%
- [GO:0005542](http://purl.obolibrary.org/obo/GO_0005542) (folic acid binding) 53.12%
- [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding) 53.12%
- [GO:0004013](http://purl.obolibrary.org/obo/GO_0004013) (adenosylhomocysteinase activity) 53.12%
- [GO:0004001](http://purl.obolibrary.org/obo/GO_0004001) (adenosine kinase activity) 53.12%
- [GO:0032559](http://purl.obolibrary.org/obo/GO_0032559) (adenyl ribonucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 53.12%
- [GO:0030554](http://purl.obolibrary.org/obo/GO_0030554) (adenyl nucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 53.12%
- [GO:0016773](http://purl.obolibrary.org/obo/GO_0016773) (phosphotransferase activity, alcohol group as acceptor) and [GO:0019206](http://purl.obolibrary.org/obo/GO_0019206) (nucleoside kinase activity) 53.12%
- [GO:0008144](http://purl.obolibrary.org/obo/GO_0008144) (drug binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 53.12%
- [GO:0030554](http://purl.obolibrary.org/obo/GO_0030554) (adenyl nucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) and [GO:0097367](http://purl.obolibrary.org/obo/GO_0097367) (carbohydrate derivative binding) 53.12%
- [GO:0030554](http://purl.obolibrary.org/obo/GO_0030554) (adenyl nucleotide binding) and [GO:0032555](http://purl.obolibrary.org/obo/GO_0032555) (purine ribonucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 53.12%
- [GO:0030554](http://purl.obolibrary.org/obo/GO_0030554) (adenyl nucleotide binding) and [GO:0032553](http://purl.obolibrary.org/obo/GO_0032553) (ribonucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 53.12%


